Understanding and minimizing late thrombosis of drug-eluting stents.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17333640.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although the safety profiles of drug-eluting stents are similar to those of bare metal stents in the short term, concern has arisen about their potential for late thrombosis (occurring > 30 days after implantation). Stent thrombosis is rare but potentially devastating and can result in ST-segment elevation myocardial infarction or death. The aim of this article is to review the incidence, predictors, pathology, and prevention of late thrombosis of drug-eluting stents.